Skip to main content

Advertisement

SpringerLink
Log in

Neuromodulation for urinary dysfunction

  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

The use of neuromodulation in the treatment of voiding dysfunction and other disorders has become an important mode of therapy in urology. As use of this therapy has increased, the body of knowledge about the physiology of micturition has grown and the technology in nerve stimulation has improved. Sacral nerve stimulation is the most frequently used form of neuromodulation, although other nerve stimulation modalities continue to be developed. Although neuromodulation is an effective treatment, the exact mechanism of action is unknown. As more light is shed on the appropriate patient selection and eventual treatment factors that best respond to neuromodulation, this therapy likely will be used earlier in the treatment course and with greater success. Use of pharmacologic agents such as botulinum toxin type A for chemical neuromodulation may also play an important role in the management of voiding dysfunction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Wein AJ, Rovner ES: Definition and epidemiology of overactive bladder. Urology 2002, 60(5 Suppl 1):7–12.

    Article  PubMed  Google Scholar 

  2. Tyagi S, Thomas CA, Hayashi Y, et al.: The overactive bladder: epidemiology and morbidity. Urol Clin North Am 2006, 33:433–438.

    Article  PubMed  Google Scholar 

  3. Tanagho EA, Schmidt RA, Orvis BR: Neural stimulation for control of voiding dysfunction: a preliminary report in 22 patients with serious neuropathic voiding disorders. J Urol 1989, 142:340–345.

    PubMed  CAS  Google Scholar 

  4. Sherman ND, Amundsen CL: Current and future techniques of neuromodulation for bladder dysfunction. Curr Urol Rep 2007, 8:448–454.

    Article  PubMed  Google Scholar 

  5. Leng WW, Chancellor MB: How sacral nerve stimulation neuromodulation works. Urol Clin North Am 2005, 23:11–18.

    Article  Google Scholar 

  6. Alo KM, Holsheimer J: New trends in neuromodulation for the management of neuropathic pain. Neurosurgery 2002, 50:690–703.

    Article  PubMed  Google Scholar 

  7. Melzack R, Wall PD: Pain mechanisms: a new theory. Science 1965, 150:971–979.

    Article  PubMed  CAS  Google Scholar 

  8. Cheng CI, Ma CP, de Groat WC: Effect of capsaicin on micturition and associated reflexes in rats. Am J Physiol 1993, 34:132–138.

    Google Scholar 

  9. van der Pal F, Heesakkers J: Current opinion on the working mechanisms of neuromodulation in the treatment of lower urinary tract dysfunction. Curr Opin Urol 2006, 16:261–267.

    Article  PubMed  Google Scholar 

  10. Vignes JR, Deloire MS, Petry KG: Animal models of sacral neuromodulation for detrusor overactivity. Neurourol Urodyn 2009, 28:8–12.

    Article  PubMed  Google Scholar 

  11. Schmidt RA, Jonas U, Oleson KA, et al.: Sacral nerve stimulation for treatment of refractory urinary urge incontinence. J Urol 1999, 62:352–357.

    Google Scholar 

  12. Blok BF, Groen J, Bosch JL, et al.: Different brain effects during chronic and acute sacral neuromodulation in urge incontinent patients with implanted neurostimulators. BJU Int 2006, 98:1238–1243.

    Article  PubMed  Google Scholar 

  13. Malaguti S, Spinelli M, Giardiello G, et al.: Neurophysiological evidence may predict the outcome of sacral neuromodulation. J Urol 2003, 170:2323–2326.

    Article  PubMed  CAS  Google Scholar 

  14. Foster RT, Anoia E, Webster GD, Amundsen CL: In patients undergoing neuromodulation for intractable urge incontinence, a reduction in 24 hour pad weight after the initial test stimulation best predicts long term patient satisfaction. Neurourol Urodyn 2007, 26:213–217.

    Article  PubMed  Google Scholar 

  15. Amundsen CL, Romero AA, Jamison MJ, Webster GD: Sacral neuromodulation for intractable urge incontinence: are there factors associated with cure? Urology 2005, 66:746–750.

    Article  PubMed  Google Scholar 

  16. Saks EK, Northington G, Gopal M, Arya L: Adherence to anticholinergic medications in women with urge incontinence [abstract P45]. Presented at the 27th Annual American Urogynecologic Society Scientific Meeting. Philadelphia, PA; October 19–21, 2006.

  17. Groenendijk PM, Lycklama à Nyeholt AA, Heesakkers JP, et al.: Urodynamic evaluation of sacral neuromodulation for urge urinary incontinence. BJU Int 2007, 101:325–329.

    Article  PubMed  Google Scholar 

  18. Tissot WD, Diokno AC, Peters KM: A referral center’s experience with transitional cell carcinoma misdiagnosed as interstitial cystitis. J Urol 2004, 172:478–480.

    Article  PubMed  Google Scholar 

  19. Bosch JL, Groen J: Sacral nerve neuromodulation in the treatment of patients with refractory motor urge incontinence: long term results of a prospective longitudinal study. J Urol 2000, 163:1219–1222.

    Article  PubMed  CAS  Google Scholar 

  20. Janknegt RA, Weil EHJ, Eerdmans PHA: Improving neuromodulation for refractory voiding dysfunctions: two stage implant. Urology 1997, 49:358–362.

    Article  PubMed  CAS  Google Scholar 

  21. Cohen BL, Tunuguntla HS, Gousse A: Predictors of success for first stage neuromodulation: motor verses sensory response. J Urol 2006, 175:2178–2181.

    Article  PubMed  Google Scholar 

  22. Spinelli M, Giardiello G, Gerber M, et al.: New sacral neuromodulation lead for percutaneous implantation using local anesthesia: description and first experience. J Urol 2003, 170:1905–1907.

    Article  PubMed  Google Scholar 

  23. Borawski K, Foster RT, Webster GD, Amundsen CL: Predicting implantation with a neuromodulator, using two different test stimulation techniques: a prospective randomized study in urge incontinence women. Neurourol Urodyn 2007, 26:14–18.

    Article  PubMed  Google Scholar 

  24. van Kerrebroeck PEV, van Voskuilen AC, Heesakkers J, et al.: Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol 2007, 178:2029–2034.

    Article  PubMed  Google Scholar 

  25. Shaker HS, Hassouna M: Sacral neuromodulation in idiopathic nonobstructive chronic urinary retention. J Urol 1998, 159:1476–1478.

    Article  PubMed  CAS  Google Scholar 

  26. Jonas U, Fowler CJ, Chancellor MB, et al.: Efficacy of sacral nerve stimulation for urinary retention: results of 18 months after implantation. J Urol 2001, 165:15–19.

    Article  PubMed  CAS  Google Scholar 

  27. Aboseif S, Tamaddon K, Chalfin S, et al.: Sacral neuromodulation in functional urinary retention: an effective way to restore voiding. BJU Int 2002, 90:662–665.

    Article  PubMed  CAS  Google Scholar 

  28. Matzel KE, Stadelmaier U, Hohenfellner M, et al.: Electrical stimulation of sacral spinal nerves for treatment of fecal incontinence. Lancet 1995, 346:1124–1127.

    Article  PubMed  CAS  Google Scholar 

  29. Leroi A, Parc Y, Lehur P, et al.: Efficacy of sacral nerve stimulation for fecal incontinence: results of a multicenter double-blind crossover study. Ann Surg 2005, 242:662–669.

    Article  PubMed  Google Scholar 

  30. Tjandra JT, Chan MK, Yeh CH, Murray-Green C: Sacral nerve stimulation is more effective than optimal medical therapy for severe fecal incontinence: a randomized, controlled study. Dis Colon Rectum 2008, 51:494–502.

    Article  PubMed  Google Scholar 

  31. Chancellor MB, de Miguel F: Treatment of overactive bladder: selective use of anticholinergic agents with low drug-drug interaction potential. Geriatrics 2007, 62:15–24.

    PubMed  Google Scholar 

  32. Amundsen CL, Webster GD: Sacral neuromodulation in an older, urge incontinent population. Am J Obstet Gynecol 2002, 187:1462–1465.

    Article  PubMed  Google Scholar 

  33. Gaynor-Krupnick DM, Dwyer NT, Rittenmeyer H, Kreder KJ: Evaluation and management of malfunctioning sacral neuromodulator. Urology 2006, 67:246–249.

    Article  PubMed  Google Scholar 

  34. Sutherland SE, Lavers A, Carlson A, et al.: Sacral nerve stimulation for voiding dysfunction: one institution’s 11 year experience. Neurourol Urodyn 2007, 26:19–28.

    Article  PubMed  Google Scholar 

  35. White WM, Mobley JD 3rd, Doggweiler R, et al.: Incidence and predictors of complications with sacral neuromodulation. Urology 2009, 73:731–735.

    Article  PubMed  Google Scholar 

  36. Huang JC, Deletis V, Vodusek DB, et al.: Preservation of pudendal afferents in sacral rhizotomies. Neurosurgery 1997, 41:411–415.

    Article  PubMed  CAS  Google Scholar 

  37. Beco J, Climov D, Bex M: Pudendal nerve decompression in perineology: a case series. BMC Surg 2004, 4:15.

    Article  PubMed  Google Scholar 

  38. Peters KM, Feber KM, Bennett RC: Sacral versus pudendal nerve stimulation for voiding dysfunction: a prospective, single-blinded, randomized, crossover trial. Neurourol Urodyn 2005, 24:643–647.

    Article  PubMed  Google Scholar 

  39. Cooperberg MR, Stoller ML: Percutaneous neuromodulation. Urol Clin North Am 2005, 32:71–78.

    Article  PubMed  Google Scholar 

  40. Govier F, Litwiller S, Nitti V, et al.: Percutaneous afferent modulation for the refractory over active bladder: results of a multicenter study. J Urol 2001, 165:1193–1198.

    Article  PubMed  CAS  Google Scholar 

  41. vanBalken MR, Vandoninck V, Gisolf K, et al.: Posterior tibial nerve stimulation as neuromodulatory treatment of lower urinary tract dysfunction. J Urol 2001, 166:914–918.

    Article  CAS  Google Scholar 

  42. Klingler HC, Pycha A, Schmidbauer J, Marberger M: Use of peripheral neuromodulation of the S3 region for treatment of detrusor overactivity: a urodynamic-based study. Urology 2000, 56:766–771.

    Article  PubMed  CAS  Google Scholar 

  43. Propert KJ, Payne CK, Kusek JW, et al.: Pitfalls in the design of clinical trials for interstitial cystitis. Urology 2002, 60:742–748.

    Article  PubMed  Google Scholar 

  44. Peters KM, Carrico DJ, Burks FB: Validation of a sham for percutaneous tibial nerve stimulation. Neurourol Urodyn 2009, 28:58–61.

    Article  PubMed  Google Scholar 

  45. Petit H, Wiart E, Gaujard E, et al.: Botulinum A toxin treatment of detrusor-sphincter dyssynergia in spinal cord disease. Spinal Cord 1998, 36:91–94.

    Article  PubMed  CAS  Google Scholar 

  46. Smith CP, Franks ME, McNeil BK, et al.: Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract. J Urol 2003, 169:1896–1900.

    Article  PubMed  CAS  Google Scholar 

  47. Wakabayashi Y, Kojima Y, Makiura Y, et al.: Acetylcholinesterase-positive axons in mucosa of urinary bladder of adult cats: retrograde tracing and degeneration studies. Histol Histopathol 2005, 10:523–530.

    Google Scholar 

  48. Sahai A, Khan MS, Dasgupta P: Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double blind, placebo controlled trial. J Urol 2007, 177:2231–2236.

    Article  PubMed  CAS  Google Scholar 

  49. Schmid DM, Sauermann P, Werner M, et al.: Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J Urol 2006, 176:177–185.

    Article  PubMed  CAS  Google Scholar 

  50. Schurch B, de Seze M, Denys P, et al.: Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 2005, 174:196–200.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. William Beaumont Hospital, 3535 West Thirteen Mile Road, Suite 438, Royal Oak, MI, 48073, USA

    Kenneth M. Peters

Authors
  1. Frank N. Burks
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenneth M. Peters
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kenneth M. Peters.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Burks, F.N., Peters, K.M. Neuromodulation for urinary dysfunction. Curr Bladder Dysfunct Rep 4, 139–144 (2009). https://doi.org/10.1007/s11884-009-0020-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-009-0020-4

Keywords

Search

Navigation